PRESTIGE CONSUMER HEALTHCARE INC.

PBH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Operating Activities
Net Income $190.3M $214.6M $209.3M $-82.3M $205.4M $164.7M $142.3M $-35.8M
Depreciation & Amortization $31.3M $30.2M $30.7M $32.6M $32.1M $30.2M $29.0M $31.8M
Depreciation $10.1M $9.7M $8.2M $7.7M $8.0M $8.5M $8.8M $10.0M
Amortization $17.9M $18.3M $19.8M $22.3M $21.5M $19.6M $19.6M $21.8M
Stock-Based Compensation $10.8M $11.2M $14.0M $12.4M
Net Cash from Operating Activities $257.6M $251.5M $248.9M $229.7M $259.9M $235.6M $217.1M $189.3M
Investing Activities
Capital Expenditures $11.2M $8.2M $9.6M $7.8M $9.6M $22.2M $14.6M $10.5M
Business Acquisitions $123.7M $8.3M $10.6M $0 $247.0M $0 $2.8M
Net Cash from Investing Activities $-136.8M $-17.5M $-20.1M $-11.6M $-256.5M $-22.2M $-16.6M $55.4M
Financing Activities
Dividends Paid
Stock Repurchases $156.3M $51.5M $25.0M $50.0M $0 $11.9M $56.7M $50.0M
Net Cash from Financing Activities $-156.1M $-182.1M $-241.0M $-185.8M $-7.6M $-279.4M $-131.4M $-249.3M
Net Change in Cash $-34.0M $51.4M $-12.0M $31.3M $-5.1M $-62.5M $67.2M $-5.0M
Free Cash Flow $246.4M $243.3M $239.4M $221.9M $250.3M $213.4M $202.6M $178.8M
← Newer Page 1 of 3 Older →
Peter Lynch

Know what you own, and know why you own it.